How the FDA’s Approval of Over-the-Counter Narcan Sales Affects the Opioid Crisis

This week, the FDA approved nationwide over-the-counter sales of Narcan, the branded version of the generic overdose reversal drug naloxone. Overdoses are the leading cause of accidental death in the United States, primarily due to opioid use. Dr. Andrew Kolodny, Co-Director of Opioid Policy Research at Brandeis University’s Heller School, joins John Yang for a chat.